Premium
Management of Exocrine Pancreatic Insufficiency in Children
Author(s) -
Sankararaman Senthilkumar,
Schindler Teresa,
Sferra Thomas J.
Publication year - 2019
Publication title -
nutrition in clinical practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.725
H-Index - 71
eISSN - 1941-2452
pISSN - 0884-5336
DOI - 10.1002/ncp.10388
Subject(s) - medicine , exocrine pancreatic insufficiency , cystic fibrosis , malabsorption , pancreatic enzymes , intensive care medicine , pediatrics , pancreatic function , gastroenterology , pancreas
The diagnosis of exocrine pancreatic insufficiency (EPI) can be difficult, as symptoms may be nonspecific. A delayed diagnosis of EPI can negatively impact health through poor weight gain, impaired growth, and malabsorption of nutrients. Because of active growth and development, children are more vulnerable to the consequences of untreated EPI. Pancreatic enzyme replacement therapy is the cornerstone of management and offers both symptomatic relief and improvement in clinical outcomes. Additionally, a high‐energy diet with unrestricted fat and supplementation with fat‐soluble vitamins is often required to optimize growth and prevent nutrition deficiencies. Cystic fibrosis (CF) is the most common condition in children that causes EPI, and improvement in nutrition management is associated with improved pulmonary function and increased survival. Currently, the management of other conditions leading to EPI in children is not well studied, and inferences from the CF literature are often necessary in caring for these patients.